Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter-based adjuvant intraperitoneal 5-fluorouracil chemotherapy for gastrointestinal carcinomatosis
2014-000882-34Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in peritoneal carcinomatosis (PC), sponsored by Ghent University Hospital. Started May 2014; status: completed.
02
Drugs
fluorouracil
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2014-000882-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000882-34.